SERA PROGNOSTICS INC-A
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About SERA
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Find out what a historical investment in SERA PROGNOSTICS INC-A would be worth today using our SERA stock calculator.
$72.33M
-
0.00%
248.21K
$1.97
$1.85
$1.92
$9.13
$1.37
Ready to start your investing journey with Stake?
Open an accountSERA FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SERA
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SERA
on Stake
Buy SERA from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of SERA from only US$10 with fractional shares
